CLINICAL_TRIALS
research
· 2026-02-03
Clinical Trial Update: Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety
Summary
This clinical trial update examines the incidence of postoperative serum hyperamylasemia after pancreatectomy and its potential impact on postoperative outcomes…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Technische Universität Dresden | Conditions: Pancreatectomy, Hyperamylasemia | Status: RECRUITING